I found the field of Pharmacology & Pharmacy very interesting. Saw the article Synthesis, structural characterization and antimycobacterial evaluation of several halogenated non-nitro benzothiazinones published in 2021. Application In Synthesis of 2,6-Difluorobenzoic acid, Reprint Addresses Seidel, RW (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Pharm, Wolfgang Langenbeck Str 4, D-06120 Halle, Saale, Germany.. The CAS is 385-00-2. Through research, I have a further understanding and discovery of 2,6-Difluorobenzoic acid
8-Nitro-1,3-benzothiazin-4-ones (BTZs), with BTZ043 and PBTZ169 as the most advanced compounds, represent a new class of potent antitubercular agents, which irreversibly inhibit decaprenylphosphoryl-beta-d-ribose-2 ‘-epimerase (DprE1), an enzyme crucial for cell wall synthesis in the pathogen Mycobacterium tuberculosis. Synthesis, structural characterization and in vitro testing against Mycobacterium aurum DSM 43999 and M. tuberculosis H(37)Rv of halogenated 2-(4-ethoxycarbonylpiperazin-1-yl)-1,3-benzothiazin-4-ones lacking a nitro group are reported. X-ray crystallography reveals that the structure of the BTZ scaffold can significantly deviate from planarity. In contrast to recent reports, the results of the present study indicate that further investigation of halogenated non-nitro BTZs for antitubercular activity is less than a promising approach.
Application In Synthesis of 2,6-Difluorobenzoic acid. About 2,6-Difluorobenzoic acid, If you have any questions, you can contact Madikizela, B; Eckhardt, T; Goddard, R; Richter, A; Lins, A; Lehmann, C; Imming, P; Seidel, RW or concate me.
Reference:
Isothiazole – Wikipedia,
,Isothiazole – ScienceDirect.com